The Department of Health and Human Services has recently announced the appointment of 21 new members to the Interagency Autism Coordinating Committee, a federal committee that advises health secretary Robert F. Kennedy Jr. on autism. The newly appointed members have stirred controversy due to their shared belief in the debunked claim that vaccines can cause autism.
This development follows concerns raised by the autism community regarding the lack of transparency in the selection process and the absence of representation from established autism research and advocacy organizations like Autism Speaks and the Simons Foundation. Instead, the new committee includes members from fringe groups that promote outdated treatments and causes of autism.
Critics have pointed out that the composition of the committee lacks the balance of expertise and perspectives seen in previous iterations. Many of the new members have ties to the Make America Healthy Again movement, aligning with Kennedy’s focus on branding autism as an “epidemic” and pushing federal health agencies to identify the cause of the condition.
Zoe Gross, director of advocacy at the Autism Self Advocacy Network, expressed concern over the committee’s potential to spread misinformation and undermine both autism research and public health efforts. The reshaping of the committee to support Kennedy’s vaccine agenda has raised alarms among researchers and advocates in the autism community.
The committee typically consists of federal members from various health agencies and public members, with the 21 new public members announced by HHS including individuals with diverse backgrounds and experiences related to autism. Some of the notable appointees include a psychiatrist, a physician specializing in treating autistic children with controversial supplements, a pediatrician focused on environmental causes of autism, and advocates for autism legislation and research.
The appointment of these new members reflects a shift in the committee’s composition towards individuals with differing perspectives on autism and vaccines. The controversy surrounding the selection process and the potential impact on autism research and advocacy underscores the importance of maintaining transparency and diversity in advisory committees like the Interagency Autism Coordinating Committee.
